Rallybio Corp (RLYB)

Schlusskurs vom Vortag:

$1.59

Offen:

$1.6

24-Stunden-Volumen:

162.42K

Marktkapitalisierung:

$69.22M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-74.56M

KGV:

-0.8557

EPS:

-1.9516

Netto-Cashflow:

$-60.27M

1W Leistung:

+7.05%

1M Leistung:

-13.02%

6M Leistung:

-12.57%

1J Leistung:

-76.68%

1-Tages-Spanne:

$1.5957

$1.69

52-Wochen-Spanne:

$1.225

$9.14

Rallybio Corp Stock (RLYB) Company Profile

Firmenname

Rallybio Corp

Sektor

Healthcare (1198)

Branche

Biotechnology (691)

Telefon

203 859 3820

Adresse

234 Church Street, Suite 1020, New Haven

Mitarbeiter

28

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

RLYB's Discussions on Twitter

Rallybio Corp Stock (RLYB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-04-17	Eingeleitet	H.C. Wainwright	Buy
2023-04-10	Eingeleitet	Wedbush	Outperform
2022-12-09	Eingeleitet	JP Morgan	Overweight
2022-02-22	Eingeleitet	JMP Securities	Mkt Outperform
2021-08-23	Eingeleitet	Cowen	Outperform
2021-08-23	Eingeleitet	Evercore ISI	Outperform
2021-08-23	Eingeleitet	Jefferies	Buy

Alle ansehen

Rallybio Corp Aktie (RLYB) Neueste Nachrichten

Nothing is Better Than Rallybio Corp (RLYB) stock at the moment – Sete News - SETE News

SETE News

Market Update: Rallybio Corp (RLYB) Sees Negative Movement, Closing at 1.56 – DWinneX - The Dwinnex

The Dwinnex

Rallybio Co. (NASDAQ:RLYB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

MarketBeat

Rallybio (NASDAQ:RLYB) Downgraded by JPMorgan Chase & Co. to Neutral - Defense World

Defense World

Rallybio Co. (NASDAQ:RLYB) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Defense World

Rallybio Co. (NASDAQ:RLYB) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Defense World

Finanzdaten der Rallybio Corp-Aktie (RLYB)

Rallybio Corp (RLYB) Nettogewinn 2024

Rallybio Corp (RLYB) Free Cashflow 2024

Rallybio Corp (RLYB) Gewinn je Aktie 2024